Practice Area

Mergers & Acquisitions

Overview

Mergers and acquisitions are among the most legally complex commercial transactions undertaken by Indian businesses. They require simultaneous management of due diligence findings, regulatory approvals, negotiation of acquisition documents, and coordination among multiple stakeholders — all under time pressure. At Corpus Lawyers, we advise acquirers, targets, and financial sponsors on M&A transactions across sectors, bringing together corporate law, regulatory advisory, and transaction structuring experience to support deals from term sheet to closing.

Legal Due Diligence

Conduct of comprehensive legal due diligence covering corporate records, material contracts, litigation, intellectual property, employment obligations, regulatory licences, and real property — with a structured diligence report that identifies material risks and deal-critical conditions precedent.

Transaction Structuring

Advisory on optimal acquisition structure — asset purchase, share purchase, merger, demerger, or slump sale — taking into account tax efficiency, regulatory approval timelines, liability ring-fencing, and the specific commercial objectives of the acquirer.

Share Purchase Agreements and SPAs

Drafting and negotiation of share purchase agreements, asset purchase agreements, and business transfer agreements; advisory on representations and warranties, indemnity frameworks, locked-box versus completion accounts mechanisms, and earn-out structures.

CCI Merger Filings

Analysis of Competition Act, 2002 thresholds for mandatory merger notification; preparation and filing of combination notifications before the Competition Commission of India; and management of the CCI review process including responses to queries.

Regulatory Approvals

Advisory on and coordination of regulatory approvals required in M&A transactions, including FEMA approvals for cross-border transactions, RBI filings, sectoral regulator approvals (SEBI, IRDAI, TRAI as applicable), and NCLT approvals for mergers under the Companies Act, 2013.

Post-Merger Integration

Advisory on post-closing integration matters including consolidation of contracts, harmonisation of employee arrangements, regulatory re-registrations, and management of completion account adjustments and earn-out disputes.

Landmark Authorities and Doctrinal Framework

Mergers and acquisitions in India operate at the intersection of the Companies Act, 2013 (Chapter XV, Sections 230-234), the Income Tax Act, 1961 (demerger and amalgamation provisions), the Competition Act, 2002 (merger control under Sections 5-6), and, for listed targets, the SEBI Takeover Regulations, 2011 and the SEBI Listing Regulations. Each leg has its own timing, its own approvals, and its own valuation disciplines.

The Companies Act, 2013 consolidated the scheme-of-arrangement jurisdiction before the NCLT, replacing the pre-2013 High Court framework. Section 230 covers compromises and arrangements; Section 231 covers scheme sanctioning and enforcement; Section 232 covers mergers and amalgamations; Section 233 introduced the fast-track merger route for small companies, holding-subsidiary combinations, and other prescribed categories. The Tribunal’s scrutiny extends to valuation, fair-exchange ratios, minority-shareholder treatment, and sectoral-regulator objections.

The Competition Act, 2002 merger-control regime under Sections 5 and 6, read with the Competition Commission of India’s Combination Regulations, requires pre-notification of combinations that exceed prescribed asset or turnover thresholds. The 2023 amendments introduced the deal-value threshold — combinations involving Indian-nexus transactions above INR 2,000 crore now require notification even where the asset-or-turnover thresholds are not met. The ex ante review regime for combinations is strictly enforced, with gun-jumping penalties imposed on transactions closed before clearance.

The SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 govern the acquisition of listed targets. An open offer is triggered at 25 percent for direct substantial acquisition, at any acquisition exceeding 5 percent in a financial year during the creeping-acquisition window, and on any change in control irrespective of shareholding. The open-offer price is fixed under Regulation 8 by reference to negotiated-price, 60-day market price, 26-week weighted average, and highest-paid prices.

Current Doctrinal Shifts and Live Questions

Deal-value threshold under CCI framework. The 2023 introduction of the deal-value threshold requires transactions with substantial Indian-nexus business operations to notify irrespective of asset or turnover levels. The interpretive position on what constitutes “substantial business operations in India” is being worked out in the CCI’s early decisions. Deal teams must now plan for a notification decision at the letter-of-intent stage, not at the closing stage.

Fast-track merger under Section 233. The Section 233 route — between a holding company and its wholly-owned subsidiary, between two or more small companies, and in other prescribed categories — avoids the NCLT scheme sanction process but requires approval from the regional director. The sequence of approvals, the nine-tenths creditor and member consent requirement, and the RoC filings are frequently mis-sequenced in practice, delaying what is designed as a fast-track route.

Foreign investment layering and Press Note 3. Press Note 3 of 2020 restricted foreign direct investment from entities incorporated in or beneficially owned from land-border countries, requiring prior government approval. Transactions involving even a minor direct or indirect beneficial interest from a land-border country attract the approval requirement. FEMA-side diligence has become a primary transaction gate for cross-border M&A, not an afterthought.

Tax-treaty grandfathering and indirect transfers. The 2012-vintage indirect-transfer amendment to Section 9 of the Income Tax Act, read with the 2021 clarification restricting its retrospective reach, continues to shape cross-border deal structuring. Treaty grandfathering under the India-Mauritius and India-Singapore treaties (for investments made before 1 April 2017) applies to legacy positions; new investments are structured under the post-grandfathering framework.

Transaction Sequencing and Closing Protection

M&A sequencing is a load-bearing exercise. A listed-target transaction sequences SEBI open-offer timing, CCI notification, Companies Act scheme sanction, and (if applicable) sectoral regulator approvals. An unlisted-target transaction sequences Section 230 or Section 233 scheme approvals, CCI where thresholds are met, and any sectoral approvals. Each approval has a window that may or may not run concurrently with the others; a mis-sequenced transaction delays closing by quarters, not weeks.

Closing protection — representations and warranties, indemnities, escrow architecture, and W&I insurance — has matured in the Indian market since 2018. W&I insurance is now available for substantial transactions, including for certain tax indemnities with specialised cover. Deal teams increasingly run parallel tracks on W&I underwriting and legal diligence so that warranty positions lock at the signing stage, not weeks after.